Lidopen

   
Google
 
Web NewDrugInformation.com

Lidopen


Drug - Lidopen
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Lidocaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 10%
The potency of the active ingredient(s), Lidocaine Hydrochloride. May repeat for multiple part products.

Applicant - MERIDIAN MEDCL TECHN
The firm name holding legal responsibility for Lidopen. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 017549
The FDA assigned number to Lidopen. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Lidopen. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Lidopen was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Lidopen. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Lidopen is in. Format is RX, OTC, DISCN.

Applicant Full Name - Meridian Medical Technologies Inc
The full name of the firm holding legal responsibility for the new application of Lidopen.

Lidopen